Dr. Dipender Gill is the CEO and Founder of Sequoia Genetics, a London-based research organization focused on leveraging human genetic data for drug discovery and development. With a distinguished medical education from the University of Oxford, including a Distinction in undergraduate training and dual degrees in Medicine, Dr. Gill completed a PhD at Imperial College London and published over 250 research papers while serving as a Clinician Scientist for more than a decade. At Novo Nordisk, Dr. Gill excelled as Principal Portfolio Scientist, generating pivotal evidence for key drug programs and achieving recognition as the most prolific academic contributor in the organization. Currently, Dr. Gill collaborates with investors and pharmaceutical companies to enhance the efficiency of drug development through human-centric evidence.
This person is not in the org chart
This person is not in any teams
This person is not in any offices